Winslow Evans & Crocker’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$4.33M Buy
55,477
+28,273
+104% +$2.16M 0.82% 24
2020
Q3
$2.15M Sell
27,204
-750
-3% -$58.7K 0.53% 43
2020
Q2
$2.06M Buy
27,954
+836
+3% +$62.9K 0.55% 39
2020
Q1
$1.99M Sell
27,118
-1,096
-4% -$86.1K 0.66% 36
2019
Q4
$2.45M Hold
28,214
0.62% 38
2019
Q3
$2.27M Buy
28,214
+306
+1% +$24.5K 0.63% 34
2019
Q2
$2.24M Buy
27,908
+987
+4% +$75.6K 0.62% 35
2019
Q1
$2.14M Sell
26,921
-117
-0.4% -$8.75K 0.61% 37
2018
Q4
$1.97M Sell
27,038
-1,084
-4% -$76.5K 0.66% 34
2018
Q3
$1.9M Buy
28,122
+1,561
+6% +$99.5K 0.58% 40
2018
Q2
$1.54M Buy
26,561
+1,204
+5% +$67.9K 0.48% 49
2018
Q1
$1.32M Buy
25,357
+209
+0.8% +$11.3K 0.43% 56
2017
Q4
$1.35M Sell
25,148
-482
-2% -$26.7K 0.43% 54
2017
Q3
$1.57M Sell
25,630
-3,155
-11% -$191K 0.52% 47
2017
Q2
$1.76M Buy
28,785
+2,872
+11% +$175K 0.48% 47
2017
Q1
$1.57M Sell
25,913
-4,018
-13% -$244K 0.49% 46
2016
Q4
$1.68M Sell
29,931
-8,248
-22% -$483K 0.52% 42
2016
Q3
$2.27M Buy
38,179
+317
+0.8% +$18.5K 0.65% 36
2016
Q2
$2.08M Buy
37,862
+139
+0.4% +$7.4K 0.62% 39
2016
Q1
$1.9M Sell
37,723
-93
-0.2% -$4.55K 0.57% 42
2015
Q4
$1.91M Buy
37,816
+1,467
+4% +$74K 0.55% 41
2015
Q3
$1.71M Sell
36,349
-430
-1% -$22.8K 0.54% 39
2015
Q2
$2M Sell
36,779
-1,475
-4% -$82.7K 0.56% 38
2015
Q1
$2.1M Sell
38,254
-1,901
-5% -$108K 0.59% 37
2014
Q4
$2.18M Buy
40,155
+79
+0.2% +$4.4K 0.62% 40
2014
Q3
$2.27M Buy
40,076
+715
+2% +$40.1K 0.65% 35
2014
Q2
$2.17M Buy
39,361
+121
+0.3% +$6.6K 0.72% 33
2014
Q1
$2.13M Sell
39,240
-1,210
-3% -$62.7K 0.73% 35
2013
Q4
$1.93M Buy
+40,450
New +$1.85M 0.66% 36

Other funds holding MRK

Winslow Evans & Crocker's MRK Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Merck (MRK) stake by 104% in Q4 2020, buying an estimated $2.16M and bringing the position to 55,477 shares worth $4.33M. The position accounts for 0.82% of the portfolio, ranked #24.

Winslow Evans & Crocker first reported a position in MRK in Q4 2013 and has held it in 29 quarters since. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Winslow Evans & Crocker held 55,477 shares of Merck worth $4.33M as of Q4 2020.
  • Winslow Evans & Crocker bought 28,273 Merck shares in Q4 2020, an estimated $2.16M.
  • Merck made up 0.82% of Winslow Evans & Crocker's portfolio in Q4 2020, its #24 holding.
  • Winslow Evans & Crocker first reported a position in Merck in Q4 2013 and has held it in 29 quarters since.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.